Skip to content

Drug interactions

Crizotinib + Dofetilide

Severity: Major

Crizotinib and Dofetilide: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs prolong the QT interval, and dofetilide has a high risk of torsades de pointes. Combining them could substantially increase the risk of life-threatening arrhythmia.

What this interaction means in plain words

Crizotinib and Dofetilide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Crizotinib belongs to Oncology; Dofetilide belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Additive QT prolongation through pharmacodynamic effects.

What to do

Avoid if possible and choose an alternative antiarrhythmic or anticancer therapy. If combined, monitor ECG and keep potassium and magnesium normal.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Crizotinib and Dofetilide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Crizotinib with Dofetilide?

MediHelp rates the interaction as major. Crizotinib and Dofetilide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs prolong the QT interval, and dofetilide has a high risk of torsades de pointes. Combining them could substantially increase the risk of life-threatening arrhythmia.

How serious is the interaction between Crizotinib and Dofetilide?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible and choose an alternative antiarrhythmic or anticancer therapy. If combined, monitor ECG and keep potassium and magnesium normal.

What other medicines interact with Crizotinib?

MediHelp also lists interactions of Crizotinib with, for example, Flibanserin, Lomitapide, Lonafarnib. The full list is on the Crizotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in